Clinical trials
Anomia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 4 |
| Unknown status | 2 |
| Suspended | 1 |
| Terminated | 1 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Albert Einstein Healthcare Network | 3 |
| The University of Texas at Dallas | 3 |
| University College, London | 3 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Georgetown University | 2 |
| Göteborg University | 2 |
| University of Nebraska Lincoln | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| Catholic University of the Sacred Heart | 1 |
| Ege University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anomia | 38 |
| Aphasia | 24 |
| Stroke | 12 |
| Communication Disorders | 9 |
| Brain Injuries | 4 |
| Brain Injuries, Traumatic | 4 |
| Aphasia, Primary Progressive | 3 |
| Alzheimer Disease | 2 |
| Aphasia, Broca | 2 |
| Dementia | 2 |
Trials
Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.